EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia ,

ISSN 2394-3211

Impact Factor: 7.065

ICV - 79.57

Abstract

PERIPHERAL NEUROPATHY ?AS ADVERSE EFFECT OF MULTI DRUG RESISTANT PULMONARY TUBERCULOSIS CHEMOTHERAPY.

*Yadav Prashant (MD) and Kumar Anand (MD)

ABSTRACT

Multidrug-resistant tuberculosis is defined as mycobacterium tuberculosis that is resistant to both isoniazid and rifampicin, with or without resistance to other drugs. Emergence and spread of multi drug resistant tuberculosis (MDR TB) can threaten the global Tuberculosis control. The treatment of MDR TB is prolonged, expensive and often unsuccessful. Drug toxicity are important factors leading to defaultation or poor treatment adherence and ultimately low cure rate in MDR TB treatment. Here we report a case of MDR Pulmonary Tuberculosis patient presented with us peripheral neuropathy as a adverse effect of second line drugs.

Keywords: MDR TB, Peripheral Neuropathy.

[Full Text Article] [Download Certificate]